Contact person
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
MVA-members receive a 15% discount on the book Scaling Life Sciences when purchased at saxo.com
"Scaling a life science company is a unique and difficult challenge. Martin Stenfeldt´s book, based on first hand experience, provides critical and actionable guidance for life science executives and startups with a need for scaling the company´s activities. A must-read for any management team planning for scaling towards growth" Mads Krogsgaard Thomsen, CEO Novo Nordisk Foundation Medicon Valley is home to some of Europe’s most ambitious life science ventures and some of its most complex...
MVA warmly welcomes The Nordic Charter for Women’s Health
Featured in the peer-reviewed journal The Lancet this week, The Nordic Charter for Women’s Health 2040 supported by among others The Copenhagen Institute for Futures Studies is a strategic framework designed to transform women’s health from a niche concern into a cornerstone of Nordic social and economic resilience. Resulting from the collective insight of over 130 contributors across Denmark, Norway, Sweden, Finland, and Iceland, gathering at Danish Parliament Dec. 8th 2025, this document...
Register for CRISPRMED26 in Copenhagen with your 15 % MVA member discount
Copenhagen hosts the world’s largest international event in CRISPR medicine: the 3rd CRISPR Medicine Conference, CRISPRMED26, taking place April 14-16, 2026 (Satellite Meetings on April 13). This annual flagship conference unites the global community of leading researchers, clinicians, industry pioneers, and innovators to push the boundaries of CRISPR medicine, from novel editing tools and delivery technologies to regulatory advances, accessibility and FTO, functional genomics, and clinical...
Register for Swiss Biotech Days with your exclusive 250 CHF (33 %) Medicon Valley Alliance member discount
Register for Swiss Biotech Days with your exclusive 250 CHF (33 %) member discount (only 20 seats - first come - first serve) As highlighted at our Annual Summit last year and documented in the latest edition of the State of the Medicon Valley analysis cross-pollination between Medicon Valley and BioValley is part of the solution to the challenge we are facing and the ambition to boost European innovation and competitiveness. Consequently, we are once again happy to offer our members an...
Interview with MVA CEO in Nordic Life Science News: “Cross-Nordic collaboration is more important than ever”
As global tensions rise and the United States moves in a more unpredictable direction, Europe’s life science sector is under pressure to strengthen its competitiveness. According to Medicon Valley Alliance’s (MVA) CEO, Anette Steenberg, the Nordics have a decisive role to play – but only if the region can act as one. This is one of the key take away messages in the recently published interview in Nordic Life Science News. The role of clusters should not be underestimated, which is why the...
Apply in AMBER’s postdoctoral call within biological imaging
The EU-funded research project AMBER, Advanced Multiscale Biological imaging using European Research infrastructures, is announcing 10 positions in its fifth postdoctoral call. Deadline 2nd Each position is funded for 36 months. Scientists holding (or about to receive soon) a PhD in the areas of physics, chemistry, medical sciences, biological sciences, or other relevant areas are welcome to apply. AMBER is coordinated by LINXS Institute of advanced Neutron and X-ray Science. Read more and...
MVA member BioInnovation Institute has been granted DKK 5.5 billion from Novo Nordisk Foundation to elevate innovation in Denmark and Europe
With the ten-year grant DKK 5.5 billion grant BII can continue to support startups and scale our activities in the Danish and European ecosystem for the foreseeable future. Since 2018, BII have supported over 130 early-stage startups within life science and deep tech, and these areas will continue to be very important to BII, but in the future areas such as AI and quantum technologies will have a much bigger focus “We are truly grateful for the long-term support from the Novo Nordisk...
New Association Secures Strong Foundation for Innovation District Copenhagen
Innovation District Copenhagen aims to become an international powerhouse for innovation, bringing together researchers, clinicians, entrepreneurs, and businesses to develop more new solutions and companies within areas such as life sciences and quantum technology. A broad coalition of partners is now establishing an association to support the long-term and sustainable development of the district. The association is founded by representatives from the state, municipality, research...
Welcome to 40 million Poles! – business column in The Copenhagen Post by David Munis Zepernick, MVA Director Member Engagement and Communication
Talent attraction is absolutely key for the life science industry in Medicon Valley in particular and for Danish economy in general. We rely heavily on immigration to keep the engine running. Immigration is, however, a hot topic and has been so for decades, because what is the optimal profile of the work force imported? I took a deep dive into some of the figures in the recently published report from Statistics Denmark mapping immigrants in Denmark. I think there are success stories which...
Join the MedTech Summit 2026!
As the first event of its kind in the Greater Copenhagen area, the MedTech Summit is fully dedicated to medical technology – created to meet the growing demand for targeted collaboration between medtech innovators and investors. With our our distinguished member companies Medeon and BioStock in the driving seat we bring together early-stage and growth-phase medtech companies with Swedish, Danish, and international investors, corporates, and partners. From diagnostics and imaging to surgical...